The CDIATM Morphine Colloidal Gold Test Cassette (Urine) is a lateral flow chromatographic immunoassay for the detection of morphine and its metabolites in human urine.
Morphine antigen is coated on the test region of the nitrocellulose membrane of the strips, and morphine antibody is labeled with colloid gold. During a test, the colloid gold labeled antibody coated in the strip move forward along the membrane, and a red line will show up when the antibody gathers with the antigen in the test line; if morphine in the sample is over the detection limit, line T is blank; on the other wise, if morphine in the sample is less than the detection limit, line T is red.
Morphine is a naturally occurring substance extracted from the seedpod of the poppy plant, Papavar somniferum. Morphine is used medicinally for the relief of moderate to severe pain in both acute and chronic management. It can also be used to sedate a patient pre-operatively and to facilitate the induction of anesthesia. The drug is also used illicitly for recreational purposes among drug users. It is potentially highly addictive and can cause intense physical dependence that leads to abuse of the substance. The CDIATM Morphine Colloidal Gold Test Cassette (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of morphine in urine. The CDIATM Morphine Colloidal Gold Test Cassette (Urine) yields a positive result when the morphine in urine exceeds 2000/600/300 ng/mL.